ERICA MOSS: Open Payments
NPI 1548492945 · RICHLAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,487 in 81 payments from 18 companies in 2025. Trend: 2023 $52 · 2024 $410 · 2025 $1,487
Food & beverage: $1,487
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $289 |
| ABBVIE INC. | 15 | $210 |
| Lilly USA, LLC | 9 | $184 |
| PFIZER INC. | 8 | $149 |
| Corcept Therapeutics | 7 | $143 |
| Novo Nordisk Inc | 5 | $96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Exact Sciences Corporation | 4 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $52 |
Products named: AIRSUPRA, Korlym, JARDIANCE, UBRELVY, ELIQUIS, MOUNJARO, QULIPTA, XIFAXAN.
Industry payments across MS — which companies pay providers there.
